Eventide Declares 5.2% Stake in Evolent Health
The investment firm’s stake spans across two registered funds and managed accounts, signaling confidence in Evolent’s market position.
May 15, 2025
Eventide Asset Management Acquires Over Six Million Shares in Evolent Health
Eventide Asset Management has taken a 5.2% position in Evolent Health, disclosing ownership of just over 6 million shares of the company’s Class A common stock. The filing, dated March 31, 2025, reflects holdings across two Eventide-managed funds and a set of separately managed accounts.
Here’s how it breaks down:
- Eventide Gilead Fund: 4.26 million shares
- Eventide Healthcare & Life Sciences Fund: 1.78 million shares
- Separately Managed Accounts: 34,000 shares
Altogether, that’s 6,077,191 shares—just over the threshold that requires public disclosure under SEC rules.
The shares are held under Eventide’s management, but Finny Kuruvilla and Robin C. John are also listed on the filing. While neither holds individual voting or dispositive control, they share that authority through their roles at the firm.
The investment was made in the ordinary course of business. It’s a passive stake—there’s no indication that Eventide, Kuruvilla, or John are looking to steer company strategy or influence leadership decisions. The filing is strictly about ownership.
About Evolent Health
Evolent Health, headquartered in Arlington, Virginia, provides specialty care solutions for health plans and providers. Its model focuses on delivering cost-effective care for complex clinical conditions—an area that has seen growing interest from investors looking to align with value-based healthcare strategies.
This isn’t a bet on a trend. It’s a portfolio allocation backed by regulatory filings, broken down by fund, and signed off by all involved parties. The firm’s position spans both mutual funds and institutional accounts, with the holdings reported collectively under SEC provisions that allow joint filings when multiple parties share ownership responsibility.
The takeaway: Eventide has made a meaningful equity investment in Evolent Health. The shares are spread across core funds and managed accounts, and the position is now on the books.
Share
Read More Articles
